Scleroderma electrocardiogram

Revision as of 20:26, 22 April 2018 by Khurram Afzal (talk | contribs)
Jump to navigation Jump to search

Scleroderma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Scleroderma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Scleroderma electrocardiogram On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Scleroderma electrocardiogram

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Scleroderma electrocardiogram

CDC on Scleroderma electrocardiogram

Scleroderma electrocardiogram in the news

Blogs on Scleroderma electrocardiogram

Directions to Hospitals Treating Scleroderma

Risk calculators and risk factors for Scleroderma electrocardiogram

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

An ECG may be helpful in the diagnosis of scleroderma heart disease. Findings on an ECG suggestive of scleroderma heart disease include left bundle branch block, right bundle branch block and septal infarction pattern. It is recommended to screen for myocardial fibrosis with an annual electrocardiogram in patients with scleroderma.

Electrocardiogram

An ECG may be helpful in the diagnosis of scleroderma heart disease. Findings on an ECG suggestive of scleroderma heart disease include:[1]


References

  1. Howard SG (September 2011). "Comment on: Berhan. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 2011;60:577-581". Diabetes. 60 (9): e25. doi:10.2337/db11-0899. PMC 3161326. PMID 21868789.
  2. Lambova S (September 2014). "Cardiac manifestations in systemic sclerosis". World J Cardiol. 6 (9): 993–1005. doi:10.4330/wjc.v6.i9.993. PMC 4176808. PMID 25276300.

Template:WH Template:WS